To include your compound in the COVID-19 Resource Center, submit it here.

Dilution is a solution

Ventrus accepts dilution for cash to carry two GI products to NDAs

Dilution is a solution

Specialty GI company Ventrus Biosciences Inc. (NASDAQ:VTUS) pocketed enough cash last week to carry its two lead products to regulatory filings, but had to sell more than a third of itself to do so.

The company raised $45

Read the full 403 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE